HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2- (4- nitrophenyl)- 4- (4- fluorophenyl)- 5- (4- pyridinyl)- 1H- imidazole

p38 MAP kinase inhibitor
Also Known As:
4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole; PD 169316; PD-169316; PD168316; PD169316; Pyridine, 4-(4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)-
Networked: 10 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cambier, Ludivine: 1 article (10/2019)
2. De Vuyst, Evelyne: 1 article (10/2019)
3. Evrard, Céline: 1 article (10/2019)
4. Faway, Emilie: 1 article (10/2019)
5. Lambert de Rouvroit, Catherine: 1 article (10/2019)
6. Mignon, Bernard: 1 article (10/2019)
7. Poumay, Yves: 1 article (10/2019)
8. Thiry, Marc: 1 article (10/2019)
9. Jeong, Hoiseon: 1 article (08/2013)
10. Kim, Aeree: 1 article (08/2013)

Related Diseases

1. Chondrosarcoma
2. Prostatic Neoplasms (Prostate Cancer)
3. Memory Disorders (Memory Loss)
4. Leukemia
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Proteins (Proteins, Gene)
3. Mitogens
4. 4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazole
5. U 0126 (UO 126)
6. Amyloid beta-Peptides
7. Calpain
8. p38 Mitogen-Activated Protein Kinases
9. SB 203580
10. Mitogen-Activated Protein Kinase Kinases (MEKs)